| 摘要 |
<p>The composition comprises (i) cowpox virus with the titer of at least 106 TCID50 per 1 mg of the total protein, (ii) disaccharide, (iii) pharmaceutically acceptable polymer, and (iv) buffer except for phosphate buffer. In addition, the invention discloses the method for preparing the stable composition containing the cowpox virus, the freeze-dried product, and method for its reconstitution.</p> |
